Quercetin ( DrugBank: Quercetin )

4 diseases

84. サルコイドーシス

臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00402623 (ClinicalTrials.gov)	January 2006	20/11/2006	The Effect of Quercetin in Sarcoidosis	The Effect of Quercetinon the Increased Inflammatory and Decreased Antioxidant Status in Sarcoidosis ...	Sarcoidosis	Dietary Supplement: quercetin;Other: placebo	Maastricht University Medical Center	ZonMw: The Netherlands Organisation for Health Research and Development	Completed	N/A	N/A	All	18	N/A	Netherlands

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02874989 (ClinicalTrials.gov)	December 16, 2016	17/8/2016	Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial	Targeted Removal of Pro-Inflammatory Cells: An Open Label Human Pilot Study in Idiopathic Pulmonary ...	Idiopathic Pulmonary Fibrosis (IPF)	Drug: Dasatinib + Quercetin;Drug: Placebo	Wake Forest University Health Sciences	Mayo Clinic;The University of Texas Health Science Center at San Antonio	Completed	50 Years	N/A	All	26	Phase 1	United States

臨床試験数 : 4 / 薬物数 : 7 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 51

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900026719	2019-11-01	2019-10-19	Clinical study for combined application of vitamin C and quercetinin the treatment of Cockayne's syn ...	Clinical study for combined application of vitamin C and quercetinin the treatment of Cockayne's syn ...	Cockayne's syndrome	test group:Vitamin C and Quercetin;	The First Medical Center of PLA General Hospital	NULL	Pending	6	13	Both	test group:20;		China

臨床試験数 : 62 / 薬物数 : 93 - (DrugBank : 30) / 標的遺伝子数 : 30 - 標的パスウェイ数 : 144

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03476330 (ClinicalTrials.gov)	May 8, 2018	19/3/2018	Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia	Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia	Fanconi Anemia;Squamous Cell Carcinoma	Drug: Quercetin (dietary supplement)	Children's Hospital Medical Center, Cincinnati	NULL	Recruiting	2 Years	N/A	All	55	Phase 2	United States
2	NCT01720147 (ClinicalTrials.gov)	July 2012	25/7/2012	Quercetin in Children With Fanconi Anemia; a Pilot Study	Quercetin in Children With Fanconi Anemia; a Pilot Study	Fanconi Anemia	Drug: Quercetin (dietary supplement)	Children's Hospital Medical Center, Cincinnati	Food and Drug Administration (FDA)	Active, not recruiting	N/A	N/A	All	30	Phase 1	United States